Diabetic Kidney Disease Risk Stratifier Helpful Tool for PCPs

Artificial intelligence was predictive of care strategies for patients with diabetic kidney disease, a new study found.
Test results from the KidneyIntelX diagnostic tool were significantly tied to how a primary care physician tailored a patient's treatment strategy, reported Manasi Datar, PhD, of Boston Healthcare Associates in Massachusetts, and colleagues.
Specifically, having a patient with a high-risk KidneyIntelX result was associated with a 64% (OR 1.64, 95% CI 1.29-2.08) higher odds of a primary care physician prescribing an SGLT-2 inhibitor with a diabetic kidney disease indication, such as canagliflozin (Invokana) which gained this expanded indication in September 2019.
The prognostic test identifying a patient as high risk was also tied to a 49% higher odds of the primary care physician increasing the patient's angiotensin II receptor blocker (ARB) dose (OR 1.49, 95% CI1.17-1.89) compared with patients who did not undergo this test.

Related Keywords

New York ,United States ,Boston ,Massachusetts ,Joseph Vassalotti ,Manasi Datar ,Pnational Kidney Foundation Spring Clinical Meeting ,National Kidney Foundation ,Icahn School Of Medicine At Mount Sinai ,Boston Healthcare Associates ,Icahn School ,Mount Sinai ,New York City ,புதியது யார்க் ,ஒன்றுபட்டது மாநிலங்களில் ,போஸ்டன் ,மாசசூசெட்ஸ் ,மனசி டாக்டர் ,தேசிய கிட்நீ அடித்தளம் வசந்த மருத்துவ சந்தித்தல் ,தேசிய கிட்நீ அடித்தளம் ,இக்ஹ்ன் பள்ளி ஆஃப் மருந்து இல் ஏற்ற சினை ,போஸ்டன் சுகாதாரம் கூட்டாளிகள் ,இக்ஹ்ன் பள்ளி ,ஏற்ற சினை ,புதியது யார்க் நகரம் ,